Legacy-Xspire Holdings, LLC Appoints Greg Stokes as Chief Executive Officer
RIDGELAND, MS – February 15, 2021 – Legacy-Xspire Holdings, LLC, parent of Wraser Pharmaceuticals, Xspire Pharma and Gentex Pharma (collectively “Legacy-Xspire”), a portfolio company of HealthEdge Investment Partners, LLC (“HealthEdge”), today announced the appointment of Gregory J. Stokes to both the Board of Managers and the position of Chief Executive Officer. Mr. Stokes joins Legacy-Xspire […]
Legacy-Xspire Holdings, LLC Acquires US and Canadian Distribution Rights for ZONTIVITY®
TAMPA, FLORIDA – September 3, 2020 – Legacy-Xspire Holdings, LLC (“Legacy”), a portfolio company of HealthEdge Investment Partners, LLC (“HealthEdge”) announced today that it has completed the acquisition of the US and Canadian distribution rights for ZONTIVITY® (Vorapaxar Sulfate) from New American Therapeutics, LLC.